Congratulations! The first IVD company in China invested by Danaher, a global leader in the life sciences industry, has received product certification.
Congratulations to Yuce Biotechnology on Obtaining Medical Device Approval
On June 20, 2022, the fully automatic fluorescence immunoassay analyzer Dx-90, designed by Shenzhen WYYL Design Co., Ltd. for Suzhou Yuce Biotechnology Co., Ltd., obtained the Class II medical device registration certificate approval (Registration Approval No.: Su Xie Zhu Zhun 20222221358) licensed by the Jiangsu Provincial Medical Products Administration.The approval of Dx-90 signifies Suzhou Yuce Biotechnology’s sufficient leading advantages in the field of hypersensitive immunoassay detection, and also indicates that the company will achieve a complete closed loop of its business model in the "industry-academia-research-medicine" transformation within the field of hypersensitive detection of novel biomarkers.
Danaher Corporation: A Giant in the Life Sciences Industry
Founded in 1984, Danaher Corporation is a Fortune 500 company and a multinational corporation with core businesses in industrial instruments and equipment. It owns numerous world-renowned brands in high-demand and attractive fields such as healthcare, environment, and industrial applications. Its key business segments include medical diagnostic platforms, life sciences platforms, among others.
Product Information
Product Name：Single-Molecule Immunoassay Analyzer
Service Brand：Yuce Biotechnology
Service Content： Industrial Design (Appearance Design), Structural Design
Design Description：
Based on the innovative concept of our client, Yuce Biotechnology—"Starting with Precision, Aspiring to Infinity"—we incorporated the "Starry Sky" design element. When you gaze at the product, you can also catch a glimpse of the outline of the universe. In addition to endowing the product with a technological aesthetic, we place greater emphasis on user experience and ergonomics.
